Table 4.
Patients with PTLD | 6 |
Patients with EBV + PCR | 5/6 (83.3%) |
Patients with histological diagnosis of PTLD | 2/6 (33.3%) |
Donor | 6 MUD |
Stem Cell Source | 5/6 (83.3%) PB 1/6 (16.6%) CB |
Conditioning Regimen (abl/RIC) | 4/2 |
GVHD prophylaxis | 5/6 (83.3%) ATG 1/6 (16.6%) Campath-1H |
Presence of □-peak | 6/6 |
Presence of Monoclonal Gammopathy | 5/6 (83.3%) |
IgGk | 2/5 (40%) |
IgGλ | 1/5 (20%) |
IgAk | 1/5 (20%) |
IgMk+IgGλ | 1/5 (20%) |
GvHD (acute vs chronic) | 2 vs 1 |